CLINICAL RESEARCH STUDIES AT ASHA
Searching for patients with
FIND OUT ABOUT E.MBRACE RESEARCH STUDY
Participants must be age 60 or over and had a Urinary Tract Infection in the past two years. Those who experience UTIs may potentially develop a bloodstream infection.
Help doctors learn about an investigational vaccine for blood infections caused by E.coli. Qualified participants will receive some study-required medical care at no cost.
DO YOU HAVE A CARDIOVASCULAR DISEASE AND ELEVATED CHOLESTEROL LEVELS? LEARN MORE ABOUT THE PREVAIL STUDY!
Our team of highly trained and experienced medical professionals is dedicated to providing the best possible care to our patients. From phlebotomists to pathologists, we work together to ensure accurate results and prompt communication.
HAVE YOU BEEN DIAGNOSED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)? THE NATIV3 TRIAL MAY BE AN OPTION FOR YOU.
NASH is a silent and progressive liver disease affecting 1 in 10 adults in the United States. Currently, there is no approved pharmaceutical treatment for the disease. Be part of developing a new NASH treatment.
ARE YOU STRUGGLING WITH COPD EVEN WHILE BEING TREATED?
If you have had a COPD exacerbation in the last 12 months that required medical attention, you may qualify to participate in a clinical research study. We are testing new investigational therapies to determine if they can reduce airway inflammation and improve COPD symptoms.